| 2 | 1/1 | 返回列表 |
| 查看: 530 | 回復(fù): 1 | ||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ,點(diǎn)擊這里進(jìn)行查看 | ||
霜葉金蟲(chóng) (小有名氣)
|
[求助]
求助翻譯一段摘要,非常感謝
|
|
|
Summary This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and toxicity of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD). Sixty-three patients with measurable metastatic colorectal carcinoma were enrolled into the study. None of the patients had received prior chemotherapy except for adjuvant setting. S-1 was administered orally twice daily at a (R)C (R)C standard dose of 80mg m day for 28 days followed by a 14-day rest. This agent is continued until disease progression, unaccepted toxicity, or patient refusal. Twenty-two (35%) of the 62 eligible patients achieved PR with a 95% confidence interval of 25(R)C48. Five of the 10 patients with a history of adjuvant chemotherapy achieved partial remission. The median survival time was 12 months. Major adverse reactions included myelosuppressive and gastrointestinal toxicities, though their incidence of grade 3 or 4 being 13% in neutropenia and less than 10% in the others. None of the 53 patients treated as outpatients required hospitalization due to adverse reactions: These results suggest that S-1 achieves similar responses to those of infusional 5-FU plus leucovorin and shows the potential of another biochemical modulation with easily manageable toxicity. |
木蟲(chóng) (小有名氣)
|
試試看 摘要:本研究旨在評(píng)測(cè)含有替加氟,5-氯-2,4-二羥基吡啶(CDHP)和氧嗪酸鉀的S-1對(duì)于轉(zhuǎn)移性結(jié)腸直腸癌病人的療效和毒副作用。這項(xiàng)評(píng)測(cè)是以5 - 氟尿嘧啶(5-FU)有針對(duì)性的抑制二氫嘧啶脫氫酶(DPD)這種生化調(diào)解作用為基礎(chǔ)的。63位檢測(cè)有轉(zhuǎn)移性大腸癌的病人參加了這項(xiàng)研究。除了輔助治療外,這些病人之前沒(méi)有接受過(guò)任何化療。病人們首先連續(xù)28天每日兩次按照(R)C(R)C標(biāo)準(zhǔn)劑量口服80mg S-1,接下來(lái)14天進(jìn)行休息。這項(xiàng)療程持續(xù)進(jìn)行到疾病擴(kuò)展、出現(xiàn)不可接受的毒性作用或者病人拒絕為止。62位符合條件的病人中有22個(gè)(35%)達(dá)到了95%的25(R)C48置信區(qū)間的PR比。10位有過(guò)輔助化療歷史的病人中有5位實(shí)現(xiàn)了部分緩解。中位生存期為12個(gè)月。主要不良反應(yīng)包括骨髓抑制和胃腸道毒性,但其3或4級(jí)發(fā)病率為13%的中性粒細(xì)胞減少,和10%的胃腸道毒性。作為門診病人的53位患者沒(méi)有因?yàn)椴涣挤磻?yīng)而需要住院的。這些結(jié)果表明S-1能夠?qū)崿F(xiàn)與注射5-FU加甲酰四氫葉酸類似的反應(yīng),并且顯示了這是一種毒性易控的生化調(diào)解方法。 |

| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 322求調(diào)劑 +3 | 宋明欣 2026-03-27 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 【求調(diào)劑】085601材料工程專碩 | 總分272 | +4 | 腳滑的守法公民 2026-03-27 | 4/200 |
|
|
[考研] 291求調(diào)劑 +12 | hhhhxn.. 2026-03-23 | 18/900 |
|
|
[考研] 07化學(xué)280分求調(diào)劑 +10 | 722865 2026-03-23 | 10/500 |
|
|
[考研] 307求調(diào)劑 +8 | 超級(jí)伊昂大王 2026-03-24 | 9/450 |
|
|
[考研] 292求調(diào)劑 +4 | 求求了收下我吧?/a> 2026-03-26 | 4/200 |
|
|
[碩博家園] 北京林業(yè)大學(xué)碩導(dǎo)招生廣告 +6 | kongweilin 2026-03-26 | 8/400 |
|
|
[考研] 調(diào)劑 +4 | 柚柚yoyo 2026-03-26 | 4/200 |
|
|
[考研] 求調(diào)劑 +6 | 白QF 2026-03-21 | 6/300 |
|
|
[考研] 化學(xué)工程085602 305分求調(diào)劑 +17 | RichLi_ 2026-03-25 | 17/850 |
|
|
[考研] 081700 調(diào)劑 267分 +11 | 迷人的哈哈 2026-03-23 | 11/550 |
|
|
[考研] 一志愿天津大學(xué)339材料與化工求調(diào)劑 +3 | 江往賣魚(yú) 2026-03-26 | 3/150 |
|
|
[考研] 303求調(diào)劑 +6 | 藍(lán)山月 2026-03-25 | 6/300 |
|
|
[考研] 材料專碩 335 分求調(diào)劑 +4 | 拒絕冷暴力 2026-03-25 | 4/200 |
|
|
[考研] 材料調(diào)劑 +3 | iwinso 2026-03-23 | 3/150 |
|
|
[考研] 318求調(diào)劑 +3 | plum李子 2026-03-23 | 3/150 |
|
|
[考研] 341求調(diào)劑(一志愿湖南大學(xué)070300) +5 | 番茄頭--- 2026-03-22 | 6/300 |
|
|
[考研] 333求調(diào)劑 +3 | ALULU4408 2026-03-23 | 3/150 |
|
|
[考研] 求老師收我 +3 | zzh16938784 2026-03-23 | 3/150 |
|
|
[考研] 266求調(diào)劑 +3 | 哇呼哼呼哼 2026-03-20 | 3/150 |
|